Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Little Green Pharma.
RELATED STOCKHEAD STORIES
News
Weed Week: France temporarily overturns CBD ban and Canada gets a classy culinary cannabis facility
Health & Biotech
ASX Health Stocks: HeraMED signs major deal for pregnancy monitoring platform
Health & Biotech
ASX Pot Stocks: Fiji Kava branches out to CBD and LGP nabs German distribution deal
Health & Biotech
What’s the best pot stock of 2021? And who’s targeting market domination in 2022?
Health & Biotech
ASX Health Stocks: The TGA rejects MMDA and magic mushrooms, deals blow to ASX psychedelic players
Health & Biotech
Weed Week: Uber Eats enters Canada’s cannabis market and Montu breaks crowdfunding records
Health & Biotech
BluView: Investors bullish on cannabis sector, and its pot stocks worth watching
Health & Biotech
Little Green Pharma ready to slide into international cannabis markets
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
Dr Boreham’s Crucible: 4 ASX stocks focused on a mind-altering $25 billion psilocybin market
Health & Biotech
The TGA could soon relax rules on psychedelics. Here are the ASX stocks that could benefit
Explainers
CBD Oil: The ultimate investor’s guide to a potential $64 billion global market
News
Weed Week: Cannabis-infused drinks market could reach US$2.8 billion by 2025
News
Pot stock Little Green Pharma flags plans to expand from cannabis to psychedelic medicines
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Pot Stocks: Roto-Gro jumps on Canniberia’s pre-approval for cannabis cultivation
Health & Biotech
